Literature DB >> 25572443

Characteristics of neck level VI lymph nodes in papillary thyroid carcinoma: correlation between nodal characteristics and primary tumor.

Jung-Soo Pyo1, Jin Hee Sohn, Guhyun Kang, Dong-Hoon Kim, Dong Hyun Kim.   

Abstract

Little is known about the pathological characteristics of metastatic and nonmetastatic lymph nodes (LNs) in papillary thyroid carcinoma (PTC). The aim of this study was to elucidate the pathological characteristics of neck level VI nodes and correlations with clinicopathological parameters. We investigated the clinicopathological features of 124 classical PTCs and characteristics of 850 dissected neck level VI LNs. Immunohistochemistry for nuclear factor-κB (NF-κB) and Ki-67 was performed on primary tumors, and correlations with nodal characteristics were investigated. Nodal metastasis at neck level VI was identified in 68 of 124 PTCs (54.8 %) and was significantly correlated with tumor size, tumor multifocality, extrathyroidal extension, and tumor stage. LN metastasis was significantly correlated with larger mean LN size (P < 0.001), larger size of the largest LN (P < 0.001), and more LNs (P < 0.001). The mean size of metastatic LNs (n = 233) was significantly larger than nonmetastatic LNs (n = 617) (P < 0.001). Primary tumor diameter significantly correlated with the largest LN size (P = 0.014, R (2) = 0.049), but not mean size or number of LNs by linear regression analysis. NF-κB and Ki-67 proliferation indexes were not significantly correlated with larger nodal size. These results suggested that characteristics of nodes and primary tumor would be useful criteria for making decisions about preoperative surveillance of nodal metastasis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25572443     DOI: 10.1007/s12022-014-9353-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  17 in total

1.  Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67.

Authors:  J Gerdes; L Li; C Schlueter; M Duchrow; C Wohlenberg; C Gerlach; I Stahmer; S Kloth; E Brandt; H D Flad
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

2.  Ultrasonographic differentiation between metastatic and benign lymph nodes in patients with papillary thyroid carcinoma.

Authors:  Pedro Weslley Souza Rosário; Sérgio de Faria; Luciano Bicalho; Maria Flávia Gatti Alves; Michelle Aparecida Ribeiro Borges; Saulo Purisch; Eduardo Lanza Padrão; Leonardo Lamego Rezende; Alvaro Luís Barroso
Journal:  J Ultrasound Med       Date:  2005-10       Impact factor: 2.153

3.  Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis.

Authors:  Jong-Lyel Roh; Jin-Man Kim; Chan Il Park
Journal:  Ann Surg Oncol       Date:  2008-07-09       Impact factor: 5.344

4.  Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.

Authors:  David S Cooper; Gerard M Doherty; Bryan R Haugen; Bryan R Hauger; Richard T Kloos; Stephanie L Lee; Susan J Mandel; Ernest L Mazzaferri; Bryan McIver; Furio Pacini; Martin Schlumberger; Steven I Sherman; David L Steward; R Michael Tuttle
Journal:  Thyroid       Date:  2009-11       Impact factor: 6.568

5.  Impairment of nuclear factor-kappaB activation increased glutamate excitotoxicity in a motoneuron-neuroblastoma hybrid cell line expressing mutant (G93A) Cu/Zn-superoxide dismutase.

Authors:  Jung-Soo Pyo; Young San Ko; Woo Ho Kim; Manho Kim; Kwang-Woo Lee; Seon Young Nam; Hee-Yong Chung; Sung Jin Cho; Tai-Kyoung Baik; Byung Lan Lee
Journal:  J Neurosci Res       Date:  2010-08-15       Impact factor: 4.164

6.  Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.

Authors:  Bomi Kim; Sun-Ju Byun; Young A Kim; Ji Eun Kim; Byung Lan Lee; Woo Ho Kim; Mee Soo Chang
Journal:  Pathology       Date:  2010-01       Impact factor: 5.306

7.  Activation of nuclear factor-κB contributes to growth and aggressiveness of papillary thyroid carcinoma.

Authors:  Jung-Soo Pyo; Guhyun Kang; Dong Hoon Kim; Seoung Wan Chae; Chanheun Park; Kyungeun Kim; Sung-Im Do; Hyun Joo Lee; Joo Heon Kim; Jin Hee Sohn
Journal:  Pathol Res Pract       Date:  2013-03-05       Impact factor: 3.250

8.  Prospective outcomes of selective lymph node dissection for papillary thyroid carcinoma based on preoperative ultrasonography.

Authors:  Iwao Sugitani; Yoshihide Fujimoto; Keiko Yamada; Noriko Yamamoto
Journal:  World J Surg       Date:  2008-11       Impact factor: 3.352

9.  The Ki-67/MIB-1 index level and recurrence of papillary thyroid carcinoma.

Authors:  Nastaran Ranjbari; Fakher Rahim
Journal:  Med Hypotheses       Date:  2013-01-10       Impact factor: 1.538

10.  Nodal status of central lymph nodes as a negative prognostic factor for papillary thyroid carcinoma.

Authors:  Yoon Se Lee; Yun-Sung Lim; Jin-Choon Lee; Soo-Geun Wang; In-Ju Kim; Seok-Man Son; Dong Hoon Shin; Byung-Joo Lee
Journal:  J Surg Oncol       Date:  2013-05-02       Impact factor: 3.454

View more
  1 in total

1.  Prognostic Role of Metastatic Lymph Node Ratio in Papillary Thyroid Carcinoma.

Authors:  Jung-Soo Pyo; Jin Hee Sohn; Kyungseek Chang
Journal:  J Pathol Transl Med       Date:  2018-08-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.